Three-dimensional cell culture is the practice of growing living cells in environments that allow them to spread, interact, and organize in all three spatial dimensions, rather than being confined to the flat bottom of a plastic dish. The difference matters because cells in a living body never experience a two-dimensional surface. They sit inside a complex mesh of proteins, signals, and neighboring cells, and their behavior changes dramatically depending on the geometry around them. The shift from flat to 3D has reshaped how researchers study disease, screen drugs, and engineer replacement tissues, and it continues to evolve rapidly across a range of techniques.
Why Flat Cultures Fall Short
For more than a century, the standard approach in biology labs has been to grow cells on flat polystyrene or glass surfaces, typically coated with a thin layer of proteins so cells can stick. These two-dimensional (2D) cultures are cheap, easy to image under a microscope, and well understood. The problem is that cells grown this way often behave nothing like the same cell type would inside a living body. When researchers compared gene expression in colorectal cancer cells grown on flat plastic versus within a 3D matrix, they found hundreds of genes expressed at significantly different levels between the two conditions, many of them directly involved in growth and cell death pathways.1PLOS ONE. Impact of the 3D Microenvironment on Phenotype, Gene Expression, and EGFR Inhibition of Colorectal Cancer Cell Lines That is not a subtle tweak. It means a drug that kills cancer cells on a flat dish might do very little to the same cells arranged in a three-dimensional mass, and vice versa.
One reason for the discrepancy is mechanical. In a living tissue, cells push and pull against a surrounding matrix and against each other, and those forces feed back into the cell’s internal signaling. This process differs substantially between 2D and 3D contexts. In three dimensions, the surrounding matrix confines cell volume and shape, and cells generate force by extending protrusions and adjusting their volume, not just through the contractile machinery that dominates on flat surfaces.2PubMed Central. Cell-extracellular matrix mechanotransduction in 3D Properties like stiffness, elasticity, and degradability of the surrounding material all influence whether a cell divides, migrates, or differentiates into a specialized type. Flat culture strips away most of these cues, leaving cells in a mechanically impoverished world that does not represent the tissue they came from.
Scaffold-Based Approaches
The most intuitive way to give cells a 3D environment is to embed them in a physical support structure. Scaffolds come in two broad flavors: natural materials derived from biological sources, and synthetic materials designed from scratch. Natural hydrogels, made from proteins like collagen or from tumor-derived basement membrane extracts, are popular because they already contain many of the chemical signals cells expect. Synthetic hydrogels, built from polymers like polyethylene glycol, offer more control over mechanical properties and composition but lack those built-in biological cues.3PubMed Central. Hydrogels as extracellular matrix mimics for 3D cell culture Both have trade-offs, and much of the field’s engineering effort goes into combining the best features of each.
Beyond gels, electrospun fiber scaffolds mimic the fibrous architecture of natural tissue. The technique shoots a polymer solution through a high-voltage electric field to produce extremely fine fibers, sometimes on the nanometer scale, that look structurally similar to the protein fibers cells encounter in vivo. A persistent challenge, though, is that the fibers pack tightly together, leaving pores too small for cells to infiltrate deeply.4PubMed Central. Strategies to Tune Electrospun Scaffold Porosity for Effective Cell Response in Tissue Engineering Researchers have found creative workarounds. One group developed a process using thermal self-agglomeration and freeze-drying to create a nanofibrous scaffold with interconnected pores up to roughly 300 micrometers across and porosity above 96%, soft and elastic enough to support bone tissue formation.5PubMed. Electrospun polycaprolactone 3D nanofibrous scaffold with interconnected and hierarchically structured pores for bone tissue engineering
Scaffold-Free Methods
Not every 3D culture needs an artificial support. Some of the most widely used techniques let cells aggregate on their own, relying on gravity or other forces. The hanging drop method is a classic example: a small droplet of cell-containing liquid is suspended upside down from a surface, and gravity pulls the cells to the bottom of the drop, where they cluster into a compact spheroid. The approach is cost-effective and produces spheroids of reproducible, controllable size.6PubMed. Principles of Hanging Drop Method (Spheroid Formation) in Cell Culture
Magnetic levitation offers a different twist. Cells are loaded with tiny magnetic nanoparticles and then suspended beneath an external magnet, which draws them together into a self-assembled spheroid without any scaffold at all.7PubMed Central. Magnetically levitated mesenchymal stem cell spheroids cultured with a collagen gel maintain phenotype and quiescence Other methods include ultra-low-attachment plates, where a special coating prevents cells from sticking to the dish so they clump together in suspension instead. These scaffold-free spheroids are simple to produce and particularly valuable for cancer research, where the compact ball of cells mimics early tumor structure.
Organoids and Self-Organization
Organoids take 3D culture a step further. Rather than forming a uniform ball, stem cells in the right growth conditions spontaneously self-organize into miniature structures that recapitulate key features of real organs, complete with multiple cell types arranged in tissue-like patterns. Cells are inherently capable of this self-organization; the field’s advances involve figuring out the right cocktail of signals to coax them into producing brain, gut, liver, kidney, or heart tissue in miniature.8PubMed Central. Building Complex Life Through Self-Organization
The complexity that organoids can achieve is striking. A recent study generated human heart organoids from pluripotent stem cells that developed a dual-chamber morphology along with a proepicardial pole, essentially recreating early structural patterning of the developing heart.9Nature Communications. A patterned human primitive heart organoid model generated by pluripotent stem cell self-organization Brain organoids, sometimes called cerebral organoids, can form layered structures resembling the developing cortex. These are not fully functional organs. They are small, simplified, and lack a blood supply. But they capture enough of the real architecture to let researchers study developmental disorders, genetic diseases, and drug responses in ways no flat culture could.
Organ-on-a-Chip Technology
Microfluidic organ-on-a-chip devices combine 3D cell culture with the controlled flow of liquids through tiny channels. The idea is to mimic not just the tissue structure but also the mechanical forces cells experience in a living body, like the shear stress of blood flowing over intestinal lining or the rhythmic stretching of breathing lungs. In one systematic study, exposing intestinal cells to fluid shear stress on a chip altered their production of mucus, the expression of tight junctions holding cells together, the formation of nutrient-absorbing microvilli, and the activity of drug-metabolizing enzymes, compared to the same cells in a static dish.10PubMed. A systematic investigation of the effect of the fluid shear stress on Caco-2 cells towards the optimization of epithelial organ-on-chip models Those differences matter enormously for predicting how a drug will be absorbed in a real gut.
More advanced multi-organ chips link several tissue compartments together with fluid channels, so that, for example, a drug processed by liver cells flows downstream to heart cells, mimicking how metabolism in one organ affects toxicity in another. These systems are still largely research tools, but they are getting closer to replacing some animal experiments in early drug development.
3D Bioprinting
Bioprinting applies additive manufacturing principles to living cells. A printer deposits cell-laden “bioinks,” typically hydrogels mixed with cells, layer by layer to build structures with precise spatial organization. Several printing approaches exist, including microextrusion, inkjet, laser-assisted printing, and stereolithography, each with different strengths in terms of resolution, speed, and cell survival.11PubMed Central. Hydrogel-based 3D bioprinting: A comprehensive review on cell-laden hydrogels, bioink formulations, and future perspectives Researchers have used bioprinting to fabricate constructs resembling skin, bone, cartilage, liver, cardiac, neural, and pancreatic tissue, among others.12PubMed. Progress in 3D bioprinting technology for tissue/organ regenerative engineering The technology is still far from printing a transplantable organ, but it has already become a practical tool for building tissue models used in research and drug testing.
Applications in Cancer Research
Cancer research has been one of the biggest beneficiaries of 3D culture. Multicellular tumor spheroids are the most widely used 3D cancer model. They can be made from a single cancer cell type or from mixtures of tumor and surrounding stromal cells, and they are used to study cell-cell interactions, metabolic adaptation, drug resistance, and processes like metastasis and blood vessel formation.13PubMed Central. Three Dimensional Engineered Models to Study Hypoxia Biology in Breast Cancer
One feature of tumor spheroids that makes them especially valuable is their ability to recreate oxygen and nutrient gradients. In larger spheroids, roughly 500 micrometers across, limited diffusion produces three distinct zones: a well-oxygenated outer shell of dividing cells, a middle hypoxic zone with low oxygen and nutrients, and a necrotic core of dead cells in the center.14Trends in Cancer. What Is 3D Cell Culture? Techniques and Applications This gradient mirrors what happens in small, poorly vascularized tumors in patients. Because hypoxia drives drug resistance and more aggressive tumor behavior, being able to study it in a dish is a significant advantage over flat cultures, which have uniform oxygen levels everywhere.
Drug Discovery and Toxicity Screening
The pharmaceutical industry has a well-known problem: drugs that look promising in the lab frequently fail in clinical trials. Part of the blame falls on 2D cell-based assays that poorly predict how a drug will behave in a living body. Three-dimensional culture models can more accurately predict drug efficacy compared to traditional flat systems.15PubMed. Generation and analysis of 3D cell culture models for drug discovery This improved predictiveness has driven the field toward higher throughput. One platform uses miniaturized 3D cultures on a micropillar and microwell chip, with human cells encapsulated in hydrogels, to perform high-content imaging for toxicity and efficacy screening at scale.16PubMed Central. High-Throughput Assessment of Mechanistic Toxicity of Chemicals in Miniaturized 3D Cell Culture Moving 3D culture from artisanal one-at-a-time experiments to automated, high-throughput workflows is an active area of development.
Personalized Medicine Through Patient-Derived Organoids
Perhaps the most exciting clinical application is using organoids grown from a patient’s own tumor to test which drugs that patient is likely to respond to, before treatment begins. Patient-derived organoids (PDOs) retain the genetic features and drug sensitivities of the tumors they came from, making them a kind of avatar for the patient’s cancer.
In metastatic colorectal cancer, researchers found a strong correlation between how PDOs responded to standard chemotherapy drugs and the patients’ actual progression-free and overall survival. When organoid response was measured against clinical outcome for two commonly used drugs, the correlations were striking, and the assay remained reliable even when miniaturized to just ten organoids per well instead of hundreds.17npj Biomedical Innovations. Accelerating personalized medicine: miniaturized patient-derived organoid drug screening for predicting cancer treatment responses and beyond In gastric cancer, a biobank of patient-derived organoids was used to identify gene expression signatures that distinguished drug-sensitive from drug-resistant patients, and the organoid-based predictions matched actual clinical responses in about 92% of tested cases.18Cell Reports Medicine. Establishment of a patient-derived gastric cancer organoid biobank to model tumor heterogeneity and predict therapeutic responses Similar results are emerging in lung cancer, where PDOs established from biopsies or pleural fluid consistently recapitulated the genomic alterations and drug sensitivity of the original tumors.19PubMed Central. Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine
These are still research findings, not routine clinical tools. Growing organoids from a patient’s tissue typically takes weeks, which can be too slow for aggressive cancers. Standardization remains an issue. But the direction is clear: 3D cultures are moving toward the clinic, not just the lab bench.
Regenerative Medicine and Tissue Engineering
Three-dimensional culture is foundational to the broader vision of growing replacement tissues and, eventually, organs. Bioprinting in particular holds promise for fabricating complex, multi-layered tissue constructs that could one day be implanted into patients.20PubMed Central. Advances in Regenerative Medicine and Tissue Engineering: Innovation and Transformation of Medicine Researchers have already bioprinted constructs that resemble skin, cartilage, bone, and other tissues, with the cells surviving the printing process and continuing to mature afterward.12PubMed. Progress in 3D bioprinting technology for tissue/organ regenerative engineering The gap between printing a tissue-like structure and producing something that functions well enough to transplant remains large, but the incremental progress is real.
The Vascularization Problem
The single biggest technical barrier to making larger, more complex 3D tissues is getting nutrients and oxygen to cells deep inside the structure. Without blood vessels, cells in the interior of a thick construct starve and die. As spheroid diameter increases, the necrotic and oxygen-depleted zones expand.21PubMed Central. Prediction of Necrotic Core and Hypoxic Zone of Multicellular Spheroids in a Microbioreactor with a U-Shaped Barrier This sets a practical size limit on any avascular 3D tissue.
Vascularization, meaning engineering functional blood-vessel-like channels into 3D constructs, is one of the most active research fronts. Bioprinting can pattern vascular precursor cells or print channels directly into a tissue construct.22PubMed Central. 3D bioprinting strategy for engineering vascularized tissue models Another approach prints a sacrificial template, a temporary structure that is later dissolved to leave behind an open channel network through which fluid can flow.23MedComm – Biomaterials and Applications. Recent advances in 3D printing sacrificial templates for fabricating engineered vasculature Neither solution has fully cracked the problem at clinically relevant scales, but progress is steady.
Reproducibility and the Matrigel Problem
A less glamorous but equally important challenge is reproducibility. Many 3D culture protocols rely on Matrigel, a gel derived from mouse tumor tissue that provides a rich mixture of basement membrane proteins. The trouble is that Matrigel’s composition varies within a single batch and between batches, which introduces uncertainty into experiments and makes results hard to reproduce across labs.24PubMed Central. Synthetic alternatives to Matrigel Because it comes from a mouse tumor, it also introduces animal-derived components, which is a problem for any application intended for human therapy.
The field is actively developing synthetic, chemically defined alternatives. Researchers have shown, for example, that retinal tissue can be differentiated from pluripotent stem cells using a synthetic oligopeptide matrix instead of Matrigel, moving toward conditions free of animal-derived materials.25PubMed. Optimizing the Conditions and Use of Synthetic Matrix for Three-Dimensional In Vitro Retinal Differentiation from Mouse Pluripotent Cells Fully replacing Matrigel across the field will take time, but synthetic alternatives are becoming increasingly capable.
Imaging presents its own reproducibility headache. Three-dimensional samples are thick, and light scatters as it travels through layers of cells and matrix. Multi-scale imaging, starting with a quick low-resolution survey and then zooming into specific areas of interest at high resolution, is often necessary. Dataset sizes scale with resolution to the third power, meaning a small increase in detail produces an enormous increase in data.26PubMed Central. Imaging 3D cell cultures with optical microscopy Standardized imaging and analysis pipelines are still being worked out.
A Shifting Regulatory Landscape
For decades, U.S. federal law required animal testing as part of the drug approval process, which limited how much weight regulators could give to results from 3D cell-based models. That changed in late 2022 with the FDA Modernization Act 2.0, which amended the original 1938 Federal Food, Drug, and Cosmetic Act so that animal testing is no longer mandated. The law explicitly clears a path for human-relevant alternatives, including 3D microphysiological systems, organoids, and organs-on-chips, to be used in preclinical safety and efficacy evaluation.27PubMed Central. FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI/ML-based approaches This does not mean animal testing has disappeared overnight. Companies and regulators are still working out what data packages using 3D models need to look like. But the legal barrier is gone, and that is accelerating investment in the technology.
3D Culture in Microgravity
An unexpected proving ground for 3D culture has been space biology. In real or simulated microgravity, various cell types spontaneously form 3D structures, because the reduced gravitational pull changes how cells adhere to each other and remodel their surrounding matrix. Devices like the NASA-developed rotating wall vessel bioreactor or ground-based clinostats simulate these conditions, and researchers have used them to generate 3D tissue from bone cells, tumor cells, and mesenchymal stem cells.28PubMed Central. The impact of simulated and real microgravity on bone cells and mesenchymal stem cells These experiments are not just curiosities. They provide insights into how gravity shapes tissue formation and could inform strategies for building tissues more efficiently on the ground.
Ethical Frontiers of Brain Organoids
As 3D culture has grown more sophisticated, it has also generated novel ethical questions that flat-culture biology never had to confront. Brain organoids, grown from human pluripotent stem cells, can develop layered cortical structures and, in some cases, spontaneous electrical oscillations resembling neural activity. This has prompted serious debate among biologists, philosophers, and ethicists about whether brain organoids could ever become conscious and, if so, what moral status they would hold.29PubMed. Brain organoids, consciousness, ethics and moral status
A second concern involves chimeras: when human brain organoids are transplanted into animal brains for research purposes, the resulting organism raises questions about how to treat an animal with partially human-derived neural tissue.30Stem Cell Reports. Ethical considerations of cerebral organoid research No current brain organoid is anywhere near conscious by any mainstream definition, and most researchers regard the concern as anticipatory rather than urgent. But the field is moving fast, and governance frameworks have not kept pace. Calls for balanced oversight that allows research to proceed while addressing public concerns and establishing clear ethical guidelines are growing louder.31PubMed Central. Brain organoids and organoid intelligence from ethical, legal, and social points of view These discussions mark a genuinely new kind of ethical territory, one that did not exist when biology’s toolkit was limited to cells on a flat piece of plastic.